Evidence map›Paper›PMID 34559050›Full record

Trial reportDiagnostic and interventional radiology (Ankara, Turkey)2021

MRI and CT in the follow-up after irreversible electroporation of small renal masses.

Mara Buijs, Daniel M de Bruin, Peter Gk Wagstaff, Patricia J Zondervan, Matthijs JV Scheltema, Marc W Engelbrecht, Maria P Laguna, Krijn P van Lienden

Open access · goldAbstract readClinical Trial, Phase II
In one paragraph

Trial report in Diagnostic and interventional radiology (Ankara, Turkey), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mara BuijsDepartment of Urology, Academic Medical Center, Amsterdam, The Netherlands.
Daniel M de BruinDepartment of Urology, Academic Medical Center, Amsterdam, The Netherlands; Department of Biomedical Engineering - Physics, Academic Medical Center, Amsterdam, The Netherlands.
Peter Gk WagstaffDepartment of Urology, Academic Medical Center, Amsterdam, The Netherlands.
Patricia J ZondervanDepartment of Urology, Academic Medical Center, Amsterdam, The Netherlands.
Matthijs JV ScheltemaDepartment of Urology, Academic Medical Center, Amsterdam, The Netherlands.
Marc W EngelbrechtDepartment of Radiology, Academic Medical Center, Amsterdam, The Netherlands.
Maria P LagunaDepartment of Urology, Istanbul Medipol University, Instanbul, Turkey.
Krijn P van LiendenDepartment of Radiology, Academic Medical Center, Amsterdam, The Netherlands.
Academic Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAblation plays a growing role in the treatment of small renal masses (SRMs) due to its nephron sparing properties and low invasiveness. Irreversible electroporation (IRE) has the potential, although still experimental, to overcome current limitations of thermal ablation. No prospective imaging studies exist of the ablation zone in the follow up after renal IRE in humans. Objectives are to assess computed tomography (CT) and magnetic resonance imaging (MRI) on the ablation zone volume (AZV), enhancement and imaging characteristics after renal IRE.

methodsProspective phase 2 study of IRE in nine patients with ten SRMs. MRI imaging was performed pre-IRE, 1 week, 3 months, 6 months and 12 months after IRE. CT was performed pre-IRE, perioperatively (direct after ablation), 3 months, 6 months and 12 months after IRE. AZVs were assessed by two independent observers. Observer variation was analyzed. Evolution of AZVs, and relation between the needle configuration volume (NCV; planned AZV) and CT- and MRI volumes were evaluated.

resultsEight SRMs were clear cell renal cell carcinomas, one SRM was a papillary renal cell carcinoma and one patient had a non-diagnostic biopsy. On CT, median AZV increased perioperatively until 3 months post-IRE (respectively, 16.8 cm3 and 6.2 cm3) compared to the NCV (4.8 cm3). On MRI, median AZV increased 1-week post-IRE until 3 months post-IRE (respectively, 14.5 cm3 and 4.6 cm3) compared to the NCV (4.8 cm3). At 6 months the AZV starts decreasing (CT 4.8 cm3; MRI 3.0 cm3), continuing at 12 months (CT 4.2 cm3, MRI 1.1 cm3). Strong correlation was demonstrated between the planning and the post-treatment volumes. Inter-observer agreement between observers was excellent (CT 95% CI 0.82-0.95, MRI 95% CI 0.86-0.96). All SRMs appeared non-enhanced immediately after ablation, except for one residual tumour. Subtraction images confirmed non-enhancement on MRI in unclear enhancement cases (3/9). Directly after IRE, gas bubbles, perinephric stranding and edema were observed in all cases.

conclusionThe AZV increases immediately on CT until 3 months after IRE. On MRI, the AZV increases at 1 week until 3 months post-IRE. At 6 months the AZV starts decreasing until 12 months post-IRE on both CT and MRI. Enhancement was absent post-IRE, except for one residual tumour. Gas bubbles, perinephric stranding and edema are normal findings directly post-IRE.

Indexed as

ElectroporationKidney NeoplasmsFollow-Up StudiesHumansMagnetic Resonance ImagingProspective StudiesTomography, X-Ray Computed

Identifiers

PMID34559050
PMCPMC8480958
OpenAlexW3193966437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.